Opinion/decision on a Paediatric investigation plan (PIP): Mekinist,Trametinib (dimethyl sulfoxide), decision type: , therapeutic area: , PIP number: P/0392/2020

Invented name Active substance

Trametinib (dimethyl sulfoxide)

Therapeutic area Decision number PIP number Pharmaceutical form(s)

Condition(s) / indication(s)

Treatment of all conditions included in the category of malignant neoplasms (except melanoma, haematopoietic and lymphoid tissue, and glioma)

Route(s) of administration Contact for public enquiries Decision type

PM: decision on the application for modification of an agreed PIP

Compliance procedure number

EMEA-C-001177-PIP01-11-M06

Compliance opinion date Compliance outcome

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Opinion/decision on a Paediatric investigation plan (PIP): Mekinist,Trametinib (dimethyl sulfoxide), decision type: , therapeutic area: , PIP number: P/0392/2020

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.